Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 May 2016 - 16 May 2016
11 May 2016 - 13 May 2016

Sonrgy in Licensing Agreement with UC San Diego for Drug Delivery Nanotech

By Doris Mendieta
Posted on 17 Feb 2014
Print article
Sonrgy, Inc. (San Diego, CA, USA), a biotechnology company developing focused drug delivery technologies, has obtained an exclusive license agreement with the University of California (UC; USA) for the company’s core technology, an ultrasound-sensitive drug delivery platform.

The agreement gives the company the sole rights to develop and market the technology worldwide. Protecting the basic technology will establish a significant barrier to potential competitors, and is a vital step towards bringing the platform to the clinic.

Based on research conducted in the lab of Prof. Sadik Esener at the UC San Diego Moores Cancer Center (USA), “the SonRx technology addresses longstanding challenges related to stability and controlled release in nanoscale drug delivery,” stated Dr. Michael Benchimol, Sonrgy’s chief technology officer. “We are excited to initiate the next steps of its commercial development.”

Sonrgy is a preclinical stage biotechnology company that is developing a targeted chemotherapy delivery platform to improve survival and quality of life for millions of cancer patients. Sonrgy’s tiny nanocarriers safely transport potent chemotherapy drugs to cancer tumors and release high doses on command in response to a focused beam of ultrasound. These carriers convey drugs directly at the tumor cell sites, avoiding the many serious side effects of toxic chemotherapy circulating in the blood stream.

Nanocarriers can deliver chemotherapy before surgery to reduce tumor size, after surgery to prevent recurrence, and in settings when surgery cannot block tumor growth. This distinctive approach to delivering chemotherapy can be applied to many tumors and it enables a more intensive treatment of the cancer, potentially optimizing effectiveness while reducing harmful effects on the rest of the body.

Related Links:

University of California, San Diego Moores Cancer Center
Sonrgy



Print article

Channels

Genomics/Proteomics

view channel

Cardiac Researchers Use Stem Cells to Generate Functional Heart Muscle

Stem cell researchers have developed a new technique to form micro-scale arrays of engineered heart muscle (EHM) from fewer than 10,000 starter cells without requirement for adherence features or extracellular matrix (ECM). Tissue engineering approaches have the potential to increase the physiologic relevance of cells,... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.